Genomics in Oncology lecture series invites Jordi Rodón, MD, PhD, Clinical Oncologist and Director of the Research Unit for Molecular Therapy of Cancer at Vall d´Hebron in Barcelona. Dr. Rodón discusses the use of next-generation sequencing to empower the future of precision medicine in oncology drug development. Learn more about genomics in oncology, visit our website here.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel